Filters

Pp-135 manufacturers

Filters

None products found

pp-135

Solution for injection

Dossier type
CTD
Dossier status
Under development
Country of origin
United States
GMP approvals
FDA
Comments
Indication: Anaemia associated with myelofibrosis; anaemia of chronic kidney disease (non-dialysis) Clinical stage: Phase 2 — MOUNTAINSIDE trial (MF anaemia) and renal anaemia study ongoing Modality: Biologic (anti-hemojuvelin monoclonal antibody) Mechanism / Target: Blocks hemojuvelin (HJV) — a BMP co-receptor — suppressing hepcidin production; allows increased iron absorption and erythropoiesis Route / form: Subcutaneous injection Differentiation: Novel HJV-targeting approach bypasses EPO/ESA resistance; addresses functional iron restriction; potential in anaemia of inflammation without erythropoiesis-stimulating agents
Manufacturer #39168

Clinical-stage company specialising in haematopoietic and porphyria diseases. Develops small molecules that modulate haem biosynthesis to treat rare blood disorders. Wholly owned pipeline with multiple Phase 3 assets in rare disease.
 

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.